✦ LIBER ✦

PReS-FINAL-2064: Effect of Goloimumab a new anti-TNF, in patients with the diagnosis of juvenile idiopathic arthritis

✍ Scribed by Kienast, A; Foeldvari, I

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Risk of new-onset uveitis in patients wi

✍ R.K. Saurenmann; A.V. Levin; B.M. Feldman; R.M. Laxer; R. Schneider; E.D. Silver 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 89 KB

PReS-FINAL-2001: The impact of adalimuma

✍ Ruperto, N; Lovell, DJ; Jarosova, K; Nemcova, D; Vargová, V; Michels, H; Chalom, 📂 Article 📅 2013 🏛 BioMed Central 🌐 English ⚖ 106 KB

Effects of anti-TNF therapy on glucose m

✍ Bárbara Santos Pires da Silva; Eloísa Bonfá; Júlio César Bertacini de Moraes; Ca 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 110 KB

PReS-FINAL-2053: Vitamin D receptor poly

✍ Falcini, F; Marini, F; Rigante, D; Bertini, F; Lepri, G; Stagi, S; Matucci Cerin 📂 Article 📅 2013 🏛 BioMed Central 🌐 English ⚖ 89 KB

PReS-FINAL-2088: Risk of severe adverse

✍ Vatta, P; Taddio, A; Lepore, L; Moressa, V; Naviglio, S; Prinzi, E 📂 Article 📅 2013 🏛 BioMed Central 🌐 English ⚖ 101 KB

PReS-FINAL-2166: Long-term safety and ef

✍ Yokota, S; Nozawa, T; Kanetaka, T; Yamazaki, K; Sato, T; Sakurai, N; Kikuchi, M 📂 Article 📅 2013 🏛 BioMed Central 🌐 English ⚖ 96 KB